Cardiovascular medicine
No incremental benefit of multisite atrial pacing compared with
right atrial pacing in patients with drug refractory paroxysmal atrial
fibrillation
T Levy, S Walker, S Rex, J Rochelle, V Paul
Department of
Cardiology, Royal Brompton and Harefield NHS Trust, Harefield Hospital,
Harefield, Middlesex UB9 6JH, UK
Correspondence to: Dr Levy. terry{at}levy77.freeserve.co.uk
Accepted 31 July 2000
OBJECTIVE
To evaluate the incremental
antifibrillatory effect of multisite atrial pacing compared with right
atrial pacing in patients with drug refractory paroxysmal atrial
fibrillation paced for arrhythmia prevention alone.
METHODS
In 20 of these patients (mean
(SD) age 64 (8) years; 14 female, six male), a single blinded
randomised crossover study was performed to investigate the incremental
benefit of one month of multisite atrial pacing compared with one month
of right atrial pacing. Outcomes included the number of episodes of
paroxysmal atrial fibrillation, their total duration obtained from
pacemaker Holter memory, and quality of life using a cardiac specific
questionnaire (the modified Karolinska questionnaire).
RESULTS
Comparing right atrial with
multisite atrial pacing, there was no significant change in either the
number of paroxysmal atrial fibrillation episodes (mean (SD): right
atrial pacing 77 (98) episodes v multisite
pacing 52 (78) episodes, NS) or their total duration (right atrial, 4.8 (5.4) days v multisite, 6.3 (9.8) days, NS).
Quality of life scores compared with baseline status were equally
improved by either pacing strategy (mean percentage improvement: right
atrial, 38%, p = 0.003; multisite, 44%, p = 0.003). There was no
significant difference in life scores comparing the two pacing modes.
CONCLUSIONS
Multisite atrial pacing
has no incremental antiarrhythmic effect compared with right atrial
pacing in patients paced for drug refractory paroxysmal atrial
fibrillation. Quality of life is equally improved with either pacing
strategy, with no differences between them.
Keywords: multisite atrial pacing; atrial fibrillation; pacing
© 2001 by Heart
This article has been cited by other articles:
-
Hakacova, N., Velimirovic, D., Margitfalvi, P., Hatala, R., Buckingham, T. A.
(2007). Septal atrial pacing for the prevention of atrial fibrillation. Europace
9: 1124-1128
[Abstract] [Full Text] -
Kantharia, B. K., Freedman, R. A., Hoekenga, D., Tomassoni, G., Worley, S., Sorrentino, R., Steinhaus, D., Wolkowicz, J. M., Syed, Z. A., and the AOP Study Investigators,
(2007). Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study. Europace
9: 1024-1030
[Abstract] [Full Text] -
Engelmann, M. D.M, Pehrson, S.
(2003). Quality of life in nonpharmacologic treatment of atrial fibrillation. Eur Heart J
24: 1387-1400
[Abstract] [Full Text] -
Schuchert, A.
(2003). Contributions of permanent cardiac pacing in the treatment of atrial fibrillation. Europace
5: S36-S41
[Abstract] [Full Text] -
Becker, R., Senges, J. C, Bauer, A., Schreiner, K. D, Voss, F., Kuebler, W., Schoels, W.
(2002). Suppression of atrial fibrillation by multisite and septal pacing in a novel experimental model. Cardiovasc Res
54: 476-481
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
